COSMOPOLITAN DIABETES FOUNDATION INC (EIN 521077958) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Principal Officer

RUSS DANSTROM

Tax Period

2024-07-01 to 2025-06-30

COSMOPOLITAN DIABETES FOUNDATION INC is a small nonprofit in the Medical Research sector that reported $217K in total revenue in fiscal year 2024. Revenue surged 31% from the prior year, signaling strong growth momentum. The organization ran a surplus of $135K, a strong 62% operating margin.

Mission

DIABETES TREATMENT, EDUCATION & RESEARCH

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $25,594

Program Service Revenue $0

Investment Income $191,101

Other Revenue $0

TOTAL REVENUE $216,695

Expense Breakdown

Grants Paid $56,045

Salaries & Benefits $0

Fundraising Expenses $1,546

Program Expenses $60,942

Other Expenses $25,600

TOTAL EXPENSES $81,645

Year-over-Year Comparison

	2024	2023	Change
Revenue	$216,695	$164,965	+0.3%
Expenses	$81,645	$61,622	+0.3%
Net Income	$135,050	$103,343	+0.3%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✓ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✓ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
DONNA CARTER	BOARD MEMBER	1.00	Director	$0	$0	$0
DICK GORDON	BOARD MEMBER	1.00	Director	$0	$0	$0
BOB WHITE	BOARD MEMBER	1.00	Director	$0	$0	$0
VICTOR SMITH	BOARD MEMBER	1.00	Director	$0	$0	$0
DON GENTRY	SECRETARY	1.00	Officer Director	$0	$0	$0
ED FICENIC	BOARD MEMBER	1.00	Director	$0	$0	$0
RUSS DANSTROM	CHAIR	2.00	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$216,695	$81,645	$1,508,131	$135,050
2024	$164,965	$61,622	$1,372,481	$103,343
2023	$101,402	$123,232	$1,266,822	$-21,830
2022	$213,406	$61,426	$1,241,675	$151,980
2021	$70,040	$46,821	$1,466,488	$23,219
2020	$77,579	$99,639	$1,196,883	$-22,060
2019	$73,926	$96,379	$1,223,664	$-22,453
2018	$74,880	$74,823	$1,196,207	$57

COSMOPOLITAN DIABETES FOUNDATION INC